|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/24 | |
| A61K 31/505 | |||
| A61K 31/397 |
| (11) | Number of the document | 2844233 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13785009.5 |
| Date of filing the European patent application | 2013-05-01 | |
| (97) | Date of publication of the European application | 2015-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/039018 |
| Date | 2013-05-01 |
| (87) | Number | WO 2013/166117 |
| Date | 2013-11-07 |
| (30) | Number | Date | Country code |
| 201261641013 P | 2012-05-01 | US |
| (72) |
DIAS, Marie, Charmaine, US
|
| (73) |
Althera Life Sciences, LLC,
1448 89 Headquarters Plaza, Morristown, NJ 07960,
US
|
| (54) | ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES |
| ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES |